Bioorthogonal reaction suitable for click/unclick applications
AssigneeDana-Farber Cancer Institute, Inc.
InventorsJustin Kim, Dahye Kang
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds and pharmaceutically acceptable salts and stereoisomers thereof that are suitable for cellular labeling or the treatment of cancer. Also disclosed are pharmaceutical compositions containing same, and methods of making and using the compounds.
Claims52
A compound having a structure represented by formula I:
- or a pharmaceutically acceptable salt or stereoisomer thereof,
- wherein:
- R1′ is a linking group;
- R1 is absent, or
- R1 and R2, together with the nitrogen atom to which they are attached, form a heterocyclyl;
- R2 is optionally substituted (C1-C8) alkyl, —C(O)R″, —C(O)OR″, —C(O)NR″R″, —S(O)R″, —S(O)2R″, (C3-C10) carbocyclyl, 4- or 7-membered heterocyclyl, or a substituted polyethylene glycol chain, wherein each R″ is independently hydrogen, (C1-C6) alkyl, (C3-C10) carbocyclyl, 4- or 7-membered heterocyclyl, and wherein said alkyl, carbocyclyl, or heterocyclyl is optionally substituted;
- and
- A1 is an active moiety.
-31. (canceled)
A compound having a structure represented by formula II or III:
- or a pharmaceutically acceptable salt or stereoisomer thereof,
- wherein:
- each X is independently CR9R9′, NR9, O, S, C(O), S(O), or SO2, wherein the ring system contains 0-3 heteroatoms;
- R9 and R9′ are independently hydrogen or a substituent;
- Y is absent or
- A2 is an active moiety;
- R4 is hydrogen, a substituent or a linking group bound to an
- group, or
- R4 and R5, together with the carbon atom to which they are attached, form a carbocyclyl or a heterocyclyl, wherein R4 is also bound to an
- group;
- R5 is hydrogen or an electron withdrawing group;
- R6 is hydrogen, a π-electron donor group, or a linking group bound to an
- group;
- R7 and R7′ are independently hydrogen or an electron withdrawing group, or
- R7 and R7′, together with the carbon atom to which they are attached, form C(O);
- R8 is hydrogen, a substituent, or a linking group bound to an
- group;
- and
- n is 1, 2, or 3,
- provided that the compound contains an
- group.
-89. (canceled)
A compound having a structure represented by formula IV or V:
- or a pharmaceutically acceptable salt or stereoisomer thereof,
- wherein:
- R1′ is a linking group;
- R1 is absent, or
- R1 and R2, together with the nitrogen atom to which they are attached, form a heterocyclyl;
- R2 is optionally substituted (C1-C8) alkyl, —C(O)R″, —C(O)OR″, —C(O)NR″R″, —S(O)R″, —S(O)2R″, (C3-C10) carbocyclyl, 4- or 7-membered heterocyclyl, or a substituted polyethylene glycol chain, wherein each R″ is independently hydrogen, (C1-C6) alkyl, (C3-C10) carbocyclyl, 4- or 7-membered heterocyclyl, and wherein said alkyl, carbocyclyl, or heterocyclyl is optionally substituted;
- each X is independently CR9R9′, NR9, O, S, C(O), S(O), or SO2, wherein the ring system contains 0-3 heteroatoms;
- R9 and R9′ are independently hydrogen or a substituent;
- A1 is an active moiety;
- Y is absent or
- A2 is an active moiety;
- R4 is hydrogen, a substituent or a linking group bound to
- or
- R4 and R5, together with the carbon atom to which they are attached, form a carbocyclyl or a heterocyclyl, wherein R4 is also bound to
- R5 is hydrogen or an electron withdrawing group;
- R6 is hydrogen, a π-electron donor group, or a linking group bound to
- R7 and R7′ are independently hydrogen or an electron withdrawing group, or
- R7 and R7′, together with the carbon atom to which they are attached, form C(O);
- R8 is hydrogen, a substituent, or a linking group bound to
- and
- n is 1, 2, or 3;
- provided that the compound contains at least one
- group.
-96. (canceled)
-108. (canceled)
(canceled)
-120. (canceled)
-131. (canceled)
(canceled)
-138. (canceled)
-143. (canceled)
(canceled)
(canceled)
-158. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
-176. (canceled)
(canceled)
A process of preparing a compound of formula IV:
- comprising reacting a compound of formula I:
- with a compound of formula II:
- or
- a process of preparing a compound of formula V:
- comprising reacting a compound of formula I:
- with a compound of formula III:
-202. (canceled)
Dependencies are inferred from the claim text.